Literature DB >> 19121634

Regulation of pancreas plasticity and malignant transformation by Akt signaling.

Lynda Elghazi1, Aaron J Weiss, Daniel J Barker, John Callaghan, Lora Staloch, Eric P Sandgren, Maureen Gannon, Volkan N Adsay, Ernesto Bernal-Mizrachi.   

Abstract

BACKGROUND & AIMS: Extensive evidence suggests that Akt signaling plays an important role in beta-cell mass and function, although its function in the regulation of the different pancreatic fates has not been adequately investigated. The goal of these studies was to assess the role of Akt signaling in the pancreatic differentiation programs.
METHODS: For these experiments, we have generated a double reporter mouse model that provides activation of Akt signaling in a cell type-specific manner. This mouse model conditionally overexpresses a constitutively active form of Akt upon Cre-mediated recombination. Activation of Akt signaling in pancreatic progenitors and acinar and beta-cells was achieved by crossing this animal model to specific Cre-lines.
RESULTS: We showed that overexpression of a constitutively active Akt in pancreatic and duodenal homeobox 1 (Pdx1) progenitors induced expansion of ductal structures expressing progenitor markers. This expansion resulted in part from increased proliferation of the ductal epithelium. Lineage-tracing experiments in mice with activation of Akt signaling in mature acinar and beta-cells suggested that acinar-to-ductal and beta-cell-to-acinar/ductal transdifferentiation also contributed to the expansion of the ductal compartment. In addition to the changes in cell plasticity, these studies demonstrated that chronic activation of Akt signaling in Pdx1 progenitors induced the development of premalignant lesions and malignant transformation in old mice.
CONCLUSIONS: The current work unravels some of the molecular mechanisms of cellular plasticity and reprogramming, and demonstrates for the first time that activation of Akt signaling regulates the fate of differentiated pancreatic cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19121634      PMCID: PMC2739876          DOI: 10.1053/j.gastro.2008.11.043

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  35 in total

1.  Hedgehog/Ras interactions regulate early stages of pancreatic cancer.

Authors:  Marina Pasca di Magliano; Shigeki Sekine; Alexandre Ermilov; Jenny Ferris; Andrzej A Dlugosz; Matthias Hebrok
Journal:  Genes Dev       Date:  2006-11-15       Impact factor: 11.361

2.  Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.

Authors:  Hideaki Ijichi; Anna Chytil; Agnieszka E Gorska; Mary E Aakre; Yoshio Fujitani; Shuko Fujitani; Christopher V E Wright; Harold L Moses
Journal:  Genes Dev       Date:  2006-11-15       Impact factor: 11.361

3.  Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation.

Authors:  Takeshi Miyatsuka; Hideaki Kaneto; Toshihiko Shiraiwa; Taka-aki Matsuoka; Kaoru Yamamoto; Ken Kato; Yumiko Nakamura; Shizuo Akira; Kiyoshi Takeda; Yoshitaka Kajimoto; Yoshimitsu Yamasaki; Eric P Sandgren; Yoshiya Kawaguchi; Christopher V E Wright; Yoshio Fujitani
Journal:  Genes Dev       Date:  2006-06-01       Impact factor: 11.361

4.  The molecular pathogenesis of pancreatic cancer: clarifying a complex circuitry.

Authors:  Anil K Rustgi
Journal:  Genes Dev       Date:  2006-11-15       Impact factor: 11.361

5.  Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes.

Authors:  H Zulewski; E J Abraham; M J Gerlach; P B Daniel; W Moritz; B Müller; M Vallejo; M K Thomas; J F Habener
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

6.  Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision.

Authors:  A Novak; C Guo; W Yang; A Nagy; C G Lobe
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

Review 7.  Genetics and biology of pancreatic ductal adenocarcinoma.

Authors:  Aram F Hezel; Alec C Kimmelman; Ben Z Stanger; Nabeel Bardeesy; Ronald A Depinho
Journal:  Genes Dev       Date:  2006-05-15       Impact factor: 11.361

8.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

Review 9.  Ductal pancreatic cancer in humans and mice.

Authors:  D A Tuveson; S R Hingorani
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005

10.  Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages.

Authors:  P L Herrera
Journal:  Development       Date:  2000-06       Impact factor: 6.868

View more
  35 in total

Review 1.  Emerging role of the KRAS-PDK1 axis in pancreatic cancer.

Authors:  Riccardo Ferro; Marco Falasca
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  PKCθ activation in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters and growth factors is needed for stimulation of numerous important cellular signaling cascades.

Authors:  Veronica Sancho; Marc J Berna; Michelle Thill; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2011-07-23

3.  A new PDAC mouse model originated from iPSCs-converted pancreatic cancer stem cells (CSCcm).

Authors:  Anna Sanchez Calle; Neha Nair; Aung KoKo Oo; Marta Prieto-Vila; Megumi Koga; Apriliana Cahya Khayrani; Maram Hussein; Laura Hurley; Arun Vaidyanath; Akimasa Seno; Yoshiaki Iwasaki; Malu Calle; Tomonari Kasai; Masaharu Seno
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

4.  p85α is a microRNA target and affects chemosensitivity in pancreatic cancer.

Authors:  Paul A Toste; Luyi Li; Brian E Kadera; Andrew H Nguyen; Linh M Tran; Nanping Wu; David L Madnick; Sanjeet G Patel; David W Dawson; Timothy R Donahue
Journal:  J Surg Res       Date:  2015-03-06       Impact factor: 2.192

5.  PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network.

Authors:  Haoqiang Ying; Kutlu G Elpek; Anant Vinjamoori; Stephanie M Zimmerman; Gerald C Chu; Haiyan Yan; Eliot Fletcher-Sananikone; Hailei Zhang; Yingchun Liu; Wei Wang; Xiaojia Ren; Hongwu Zheng; Alec C Kimmelman; Ji-hye Paik; Carol Lim; Samuel R Perry; Shan Jiang; Brian Malinn; Alexei Protopopov; Simona Colla; Yonghong Xiao; Aram F Hezel; Nabeel Bardeesy; Shannon J Turley; Y Alan Wang; Lynda Chin; Sarah P Thayer; Ronald A DePinho
Journal:  Cancer Discov       Date:  2011-05-23       Impact factor: 39.397

Review 6.  Acinar cell plasticity and development of pancreatic ductal adenocarcinoma.

Authors:  Peter Storz
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-08       Impact factor: 46.802

Review 7.  KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.

Authors:  John P Morris; Sam C Wang; Matthias Hebrok
Journal:  Nat Rev Cancer       Date:  2010-09-03       Impact factor: 60.716

8.  Ras, PI3K/Akt and senescence: Paradoxes provide clues for pancreatic cancer therapy.

Authors:  Alyssa L Kennedy; Peter D Adams; Jennifer P Morton
Journal:  Small GTPases       Date:  2011-09-01

Review 9.  Molecular and cellular regulation of pancreatic acinar cell function.

Authors:  Sohail Husain; Edwin Thrower
Journal:  Curr Opin Gastroenterol       Date:  2009-09       Impact factor: 3.287

10.  Crosstalk Between Activated Myofibroblasts and β Cells in Injured Mouse Pancreas.

Authors:  Jennifer-Ann Bayan; Zhechu Peng; Ni Zeng; Lina He; Jingyu Chen; Bangyan L Stiles
Journal:  Pancreas       Date:  2015-10       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.